ASSURE HOLDINGS CORP (IONM) Fundamental Analysis & Valuation

NASDAQ:IONM • US04625J3032

Current stock price

2.43 USD
-0.32 (-11.64%)
At close:
1.85 USD
-0.58 (-23.87%)
After Hours:

This IONM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IONM Profitability Analysis

1.1 Basic Checks

  • In the past year IONM has reported negative net income.
  • In the past year IONM has reported a negative cash flow from operations.
IONM Yearly Net Income VS EBIT VS OCF VS FCFIONM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 -10M -20M -30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -251.76%, IONM is doing worse than 96.55% of the companies in the same industry.
Industry RankSector Rank
ROA -251.76%
ROE N/A
ROIC N/A
ROA(3y)-58.19%
ROA(5y)-30.71%
ROE(3y)-212.76%
ROE(5y)-111.27%
ROIC(3y)N/A
ROIC(5y)N/A
IONM Yearly ROA, ROE, ROICIONM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 -200 -400

1.3 Margins

  • IONM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IONM Yearly Profit, Operating, Gross MarginsIONM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300 -400

2

2. IONM Health Analysis

2.1 Basic Checks

  • IONM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IONM has more shares outstanding
  • Compared to 1 year ago, IONM has a worse debt to assets ratio.
IONM Yearly Shares OutstandingIONM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 200K 400K 600K 800K 1M
IONM Yearly Total Debt VS Total AssetsIONM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

  • IONM has an Altman-Z score of -11.27. This is a bad value and indicates that IONM is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of IONM (-11.27) is worse than 89.66% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -11.27
ROIC/WACCN/A
WACC8.41%
IONM Yearly LT Debt VS Equity VS FCFIONM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M

2.3 Liquidity

  • IONM has a Current Ratio of 1.50. This is a normal value and indicates that IONM is financially healthy and should not expect problems in meeting its short term obligations.
  • IONM has a Current ratio of 1.50. This is comparable to the rest of the industry: IONM outperforms 56.90% of its industry peers.
  • A Quick Ratio of 1.50 indicates that IONM should not have too much problems paying its short term obligations.
  • The Quick ratio of IONM (1.50) is better than 60.34% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.5
IONM Yearly Current Assets VS Current LiabilitesIONM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

4

3. IONM Growth Analysis

3.1 Past

  • The earnings per share for IONM have decreased strongly by -6836.67% in the last year.
  • The Revenue for IONM has decreased by -62.38% in the past year. This is quite bad
  • Measured over the past years, IONM shows a decrease in Revenue. The Revenue has been decreasing by -7.02% on average per year.
EPS 1Y (TTM)-6836.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.62%
Revenue 1Y (TTM)-62.38%
Revenue growth 3Y-14.76%
Revenue growth 5Y-7.02%
Sales Q2Q%-99.72%

3.2 Future

  • The Earnings Per Share is expected to grow by 24.90% on average over the next years. This is a very strong growth
  • IONM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 35.16% yearly.
EPS Next Y95.91%
EPS Next 2Y41.18%
EPS Next 3Y24.9%
EPS Next 5YN/A
Revenue Next Year13.65%
Revenue Next 2Y26.35%
Revenue Next 3Y35.16%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IONM Yearly Revenue VS EstimatesIONM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
IONM Yearly EPS VS EstimatesIONM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -200 -400 -600

1

4. IONM Valuation Analysis

4.1 Price/Earnings Ratio

  • IONM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year IONM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IONM Price Earnings VS Forward Price EarningsIONM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IONM Per share dataIONM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

  • IONM's earnings are expected to grow with 24.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.18%
EPS Next 3Y24.9%

0

5. IONM Dividend Analysis

5.1 Amount

  • IONM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IONM Fundamentals: All Metrics, Ratios and Statistics

ASSURE HOLDINGS CORP

NASDAQ:IONM (7/23/2024, 8:17:36 PM)

After market: 1.85 -0.58 (-23.87%)

2.43

-0.32 (-11.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)06-07
Earnings (Next)08-12
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners126.89%
Ins Owner Change0%
Market Cap1.43M
Revenue(TTM)10.98M
Net Income(TTM)-38.50M
Analysts82.86
Price Target4.08 (67.9%)
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-210.59%
Min EPS beat(2)-435.95%
Max EPS beat(2)14.77%
EPS beat(4)1
Avg EPS beat(4)-601.37%
Min EPS beat(4)-1923.47%
Max EPS beat(4)14.77%
EPS beat(8)1
Avg EPS beat(8)-334.84%
EPS beat(12)2
Avg EPS beat(12)-279.28%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-77.49%
Min Revenue beat(2)-84.04%
Max Revenue beat(2)-70.94%
Revenue beat(4)0
Avg Revenue beat(4)-73.34%
Min Revenue beat(4)-122.72%
Max Revenue beat(4)-15.67%
Revenue beat(8)1
Avg Revenue beat(8)-51.15%
Revenue beat(12)3
Avg Revenue beat(12)-32.93%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-41.62
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-12.95
FCFYN/A
OCF(TTM)-12.86
OCFYN/A
SpS6.05
BVpS-10.29
TBVpS-10.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -251.76%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-58.19%
ROA(5y)-30.71%
ROE(3y)-212.76%
ROE(5y)-111.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.5
Altman-Z -11.27
F-Score1
WACC8.41%
ROIC/WACCN/A
Cap/Depr(3y)11.22%
Cap/Depr(5y)23.22%
Cap/Sales(3y)3.27%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6836.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.62%
EPS Next Y95.91%
EPS Next 2Y41.18%
EPS Next 3Y24.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-62.38%
Revenue growth 3Y-14.76%
Revenue growth 5Y-7.02%
Sales Q2Q%-99.72%
Revenue Next Year13.65%
Revenue Next 2Y26.35%
Revenue Next 3Y35.16%
Revenue Next 5YN/A
EBIT growth 1Y-156.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.04%
EBIT Next 3Y32.63%
EBIT Next 5YN/A
FCF growth 1Y25.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.35%
OCF growth 3YN/A
OCF growth 5YN/A

ASSURE HOLDINGS CORP / IONM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ASSURE HOLDINGS CORP?

ChartMill assigns a fundamental rating of 2 / 10 to IONM.


What is the valuation status of ASSURE HOLDINGS CORP (IONM) stock?

ChartMill assigns a valuation rating of 1 / 10 to ASSURE HOLDINGS CORP (IONM). This can be considered as Overvalued.


How profitable is ASSURE HOLDINGS CORP (IONM) stock?

ASSURE HOLDINGS CORP (IONM) has a profitability rating of 0 / 10.


How financially healthy is ASSURE HOLDINGS CORP?

The financial health rating of ASSURE HOLDINGS CORP (IONM) is 2 / 10.